cd19

  1. B

    TAME – CD19-Targeted B-Cell Therapy for Post-Infectious Autoimmune ME/CFS Using the Monoclonal Antibody Tafasitamab

    https://projects.mecfs-research.org/en/projects/tame Growing scientific evidence suggests that autoantibodies and dysregulated B cells play a significant role in a subset of ME/CFS patients. In studies—including those conducted at Charité – Universitätsmedizin Berlin—immunoadsorption (the...
  2. Chandelier

    CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial, 2026, Albach et al.

    CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial Abstract Chimeric antigen receptor (CAR) T cell-mediated B cell depletion has demonstrated efficacy in several autoimmune diseases. Here we report clinical and molecular data obtained during...
  3. SNT Gatchaman

    Immune disturbances in individuals with post-COVID syndrome are not characterized by enhanced SARS-CoV-2-specific immunity, 2025, Ober+

    Immune disturbances in individuals with post-COVID syndrome are not characterized by enhanced SARS-CoV-2-specific immunity Ober, Veronica; Völk, Felix; Sbierski-Kind, Julia; Gruener, Eva; Stirner, Renate; Reiling, Gabriele; Feldmann, Svenja; Ibarra, Gerardo; Seybold, Ulrich; Stubbe, Hans...
Back
Top Bottom